These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11277)

  • 1. Extrapyramidal effects of neuroleptics.
    Korczyn AD; Goldberg GJ
    J Neurol Neurosurg Psychiatry; 1976 Sep; 39(9):866-9. PubMed ID: 11277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiparkinsonian agents and long-term neuroleptic treatment. Effect of G 31.406, orphenadrine, and placebo on parkinsonism, schizophrenic symptoms, depression and anxiety.
    Gerlach J; Rasmussen PT; Hansen L; Kristjansen P
    Acta Psychiatr Scand; 1977 Apr; 55(4):251-60. PubMed ID: 324238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
    Ekdawi MY; Fowke R
    Br J Psychiatry; 1966 Jun; 112(487):633-6. PubMed ID: 5964267
    [No Abstract]   [Full Text] [Related]  

  • 6. [The drug-induced Parkinson's syndrome].
    Pakesch E
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):140-6. PubMed ID: 4226879
    [No Abstract]   [Full Text] [Related]  

  • 7. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 9. Oestrogens and extrapyramidal system.
    Bedard P; Langelier P; Villeneuve A
    Lancet; 1977 Dec 24-31; 2(8052-8053):1367-8. PubMed ID: 74783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of extrapyramidal manifestations induced by neuroleptics].
    Bordeleau JM; Tétreault L
    Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extrapyramidal complications of psychopharmacological drugs].
    Vacek J
    Cesk Psychiatr; 1969 Dec; 65(6):414-21. PubMed ID: 4983105
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced extrapyramidal syndromes.
    Lader MH
    J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extrapyramidal symptoms during the use of neuroleptics].
    Ditfurth HV
    Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
    Mindham RH; Gaind R; Anstee BH; Rimmer L
    Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia.
    Morris PA; MacKenzie DH; Masheter HC
    Br J Psychiatry; 1970 Dec; 117(541):683-4. PubMed ID: 4923721
    [No Abstract]   [Full Text] [Related]  

  • 17. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV; Ananth JV; Ban TA; Lehmann HE
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):289-91. PubMed ID: 4931413
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.
    Fann WE; Lake CR
    Am J Psychiatry; 1976 Aug; 133(8):940-3. PubMed ID: 782262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Persisting extrapyramidal syndrome following neuroleptic therapy].
    Nehlil J
    Rev Neurol (Paris); 1969 Apr; 120(4):270-1. PubMed ID: 5343622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.